Skip to main content
AAN.com
Articles
February 1, 1987

A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

February 1987 issue
37 (2) 226

Abstract

From 1967 to 1979, 118 incident cases of idiopathic Parkinson's disease (IPD) and 236 age- and sex-matched controls from Rochester, MN, were identified. Medical records on patients and controls for 40 years preceding the diagnosis of IPD were reviewed. The relative risk (RR) for ever-smoked and IPD was not significantly different from unity (RR = 0.7, 95% confidence interval = 0.4 to 1.2). The mean age at diagnosis of IPD was significantly younger (p = 0.007) in the ever-smokers (68.8 years) compared with never-smokers (73.8 years), although this needs to be interpreted cautiously. It is concluded that smoking had no effect on the development of IPD. Within 5 years after the index date, a new diagnosis of dementia was made more often in cases than in controls (p = 0.01). Relative risk of IPD significantly increased when prior diagnosis of psychoneurosis and psychosomatic illness had been made.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 37Number 2February 1987
Pages: 226
PubMed: 3808303

Publication History

Published online: February 1, 1987
Published in print: February 1987

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

A. H. Rajput, FRCP(C)
Department of Clinical Neurological Sciences (Dr. Rajput). University of Saskatchewan, Saskatoon, Saskatchewan, Canada; and the Department of Medical Statistics and Epidemiology (Mr. Offord, Ms. Beard, and Dr. Kurland), Mayo Clinic, Rochester, MN.
Kenneth P. Offord, MS
Department of Clinical Neurological Sciences (Dr. Rajput). University of Saskatchewan, Saskatoon, Saskatchewan, Canada; and the Department of Medical Statistics and Epidemiology (Mr. Offord, Ms. Beard, and Dr. Kurland), Mayo Clinic, Rochester, MN.
C. Mary Beard, RN, MPH
Department of Clinical Neurological Sciences (Dr. Rajput). University of Saskatchewan, Saskatoon, Saskatchewan, Canada; and the Department of Medical Statistics and Epidemiology (Mr. Offord, Ms. Beard, and Dr. Kurland), Mayo Clinic, Rochester, MN.
L. T. Kurland, MD, DrPH
Department of Clinical Neurological Sciences (Dr. Rajput). University of Saskatchewan, Saskatoon, Saskatchewan, Canada; and the Department of Medical Statistics and Epidemiology (Mr. Offord, Ms. Beard, and Dr. Kurland), Mayo Clinic, Rochester, MN.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Risk of Dementia in Parkinson's Disease: A Systematic Review and Meta‐Analysis, Movement Disorders, 39, 10, (1697-1709), (2024).https://doi.org/10.1002/mds.29918
    Crossref
  2. Epidemiology of Parkinson’s Disease—Current Understanding of Causation and Risk Factors, Techniques for Assessment of Parkinsonism for Diagnosis and Rehabilitation, (31-48), (2021).https://doi.org/10.1007/978-981-16-3056-9_3
    Crossref
  3. Risk factors for dementia diagnosis in German primary care practices, International Psychogeriatrics, 28, 7, (1059-1065), (2016).https://doi.org/10.1017/S1041610215002082
    Crossref
  4. Early Nicotine Exposure Is Protective in Familial and Idiopathic Models of Parkinson’s Disease, Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease, (219-229), (2016).https://doi.org/10.1007/978-3-319-42139-1_11
    Crossref
  5. Frequency and Cause of Parkinson’s Disease, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 19, S1, (103-107), (2015).https://doi.org/10.1017/S0317167100041457
    Crossref
  6. Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study, Annals of Epidemiology, 24, 3, (206-213), (2014).https://doi.org/10.1016/j.annepidem.2013.12.010
    Crossref
  7. Genetic comorbidities in Parkinson's disease, Human Molecular Genetics, 23, 3, (831-841), (2013).https://doi.org/10.1093/hmg/ddt465
    Crossref
  8. Dementias, Neurology in Clinical Practice, (1534-1582), (2012).https://doi.org/10.1016/B978-1-4377-0434-1.00091-8
    Crossref
  9. The relevance of clinical subtypes for disease course, family history and epidemiological variables in Parkinson's disease, European Journal of Neurology, 1, 1, (65-72), (2011).https://doi.org/10.1111/j.1468-1331.1994.tb00052.x
    Crossref
  10. Epidemiology and etiology of Parkinson’s disease: a review of the evidence, European Journal of Epidemiology, 26, S1, (1-58), (2011).https://doi.org/10.1007/s10654-011-9581-6
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share